{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T14:29:00Z","timestamp":1779114540393,"version":"3.51.4"},"reference-count":30,"publisher":"Public Library of Science (PLoS)","issue":"6","license":[{"start":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T00:00:00Z","timestamp":1687305600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"The Navamindradhiraj University Research Fund","award":["COA 149\/64"],"award-info":[{"award-number":["COA 149\/64"]}]}],"content-domain":{"domain":["www.plosone.org"],"crossmark-restriction":false},"short-container-title":["PLoS ONE"],"abstract":"<jats:p>Patients with mild-to-moderate coronavirus disease 2019 (COVID-19)-associated acute respiratory distress syndrome (ARDS) can be treated with a high-flow nasal cannula (HFNC). The use of the respiratory rate-oxygenation (ROX) index, calculated as the ratio of oxygen saturation (SpO<jats:sub>2<\/jats:sub>)\/fractional oxygen (FiO<jats:sub>2<\/jats:sub>) to respiratory rate, in the first few hours after HFNC initiation can help identify patients who fail HFNC therapy later. However, few studies have documented the use of the ROX index during the period of HFNC therapy. Therefore, we aimed to demonstrate the diagnostic performance of the ROX index when calculated throughout the HFNC therapy period and to determine the best cut-off point for predicting HFNC failure. We conducted a retrospective study of patients with COVID-19-associated ARDS who commenced HFNC at the Faculty of Medicine Vajira Hospital, Navamindradhiraj University, Thailand, between April 1 and August 30, 2021. We calculated the ROX index every 4 h throughout the HFNC therapy period and defined HFNC failure as a subsequent endotracheal tube intubation. The performance of the ROX index was analyzed using the area under the receiver operating characteristic curve (AUC). We applied the ROX index \u2264 4.88 to predict HFNC failure and obtained a new ROX cut-off point using Youden\u2019s method. In total, 212 patients with COVID-19 treated with HFNC were included in the study. Of these, 81 patients (38.2%) experienced HFNC failure. The ROX index \u2264 4.88 demonstrated a reasonable performance in predicting HFNC failure (AUC, 0.77; 95% confidence interval [CI], 0.72\u20130.83; p&lt;0.001). However, compared with the original cut-off point of \u2264 4.88, the new ROX index cut-off point of \u2264 5.84 delivered optimal performance (AUC, 0.84; 95% CI, 0.79\u20130.88; p&lt;0.001), with a significantly better discriminative ability (p = 0.007). In conclusion, a ROX index \u2264 5.84 was found to be optimal for predicting HFNC failure in patients with COVID-19-associated ARDS.<\/jats:p>","DOI":"10.1371\/journal.pone.0287432","type":"journal-article","created":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T19:11:04Z","timestamp":1687374664000},"page":"e0287432","update-policy":"https:\/\/doi.org\/10.1371\/journal.pone.corrections_policy","source":"Crossref","is-referenced-by-count":9,"title":["The use of respiratory rate-oxygenation index to predict failure of high-flow nasal cannula in patients with coronavirus disease 2019-associated acute respiratory distress syndrome: A retrospective study"],"prefix":"10.1371","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4019-7632","authenticated-orcid":true,"given":"Sujaree","family":"Poopipatpab","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pruchwilai","family":"Nuchpramool","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Piyarat","family":"Phairatwet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Todspol","family":"Lertwattanachai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2544-7322","authenticated-orcid":true,"given":"Konlawij","family":"Trongtrakul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"340","published-online":{"date-parts":[[2023,6,21]]},"reference":[{"issue":"3","key":"pone.0287432.ref001","article-title":"Report of the WHO-China joint mission on coronavirus disease 2019 (COVID-19)","volume":"2","author":"C. Gomes","year":"2020","journal-title":"Brazilian Journal of Implantology and Health Sciences"},{"issue":"10223","key":"pone.0287432.ref002","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/S0140-6736(20)30211-7","article-title":"Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study","volume":"395","author":"N Chen","year":"2020","journal-title":"Lancet"},{"issue":"11","key":"pone.0287432.ref003","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1001\/jama.2020.1585","article-title":"Clinical Characteristics of 138 Hospitalized Patients With 2019 Novel Coronavirus-Infected Pneumonia in Wuhan, China","volume":"323","author":"D Wang","year":"2020","journal-title":"JAMA"},{"issue":"5","key":"pone.0287432.ref004","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S2213-2600(20)30079-5","article-title":"Clinical course and outcomes of critically ill patients with SARS-CoV-2 pneumonia in Wuhan, China: a single-centered, retrospective, observational study","volume":"8","author":"X Yang","year":"2020","journal-title":"Lancet Respir Med"},{"issue":"21","key":"pone.0287432.ref005","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1056\/NEJMoa2004500","article-title":"Covid-19 in Critically Ill Patients in the Seattle Region\u2014Case Series","volume":"382","author":"PK Bhatraju","year":"2020","journal-title":"N Engl J Med"},{"issue":"16","key":"pone.0287432.ref006","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1001\/jama.2020.5394","article-title":"Baseline Characteristics and Outcomes of 1591 Patients Infected With SARS-CoV-2 Admitted to ICUs of the Lombardy Region, Italy","volume":"323","author":"G Grasselli","year":"2020","journal-title":"Jama"},{"issue":"8","key":"pone.0287432.ref007","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1007\/s00134-021-06459-2","article-title":"Non-invasive ventilatory support and high-flow nasal oxygen as first-line treatment of acute hypoxemic respiratory failure and ARDS","volume":"47","author":"DL Grieco","year":"2021","journal-title":"Intensive Care Med"},{"issue":"1","key":"pone.0287432.ref008","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.bja.2020.03.025","article-title":"Anaesthesia and COVID-19: infection control","volume":"125","author":"PM Odor","year":"2020","journal-title":"Br J Anaesth"},{"issue":"1","key":"pone.0287432.ref009","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s13756-020-00763-0","article-title":"Risk of SARS-CoV-2 transmission by aerosols, the rational use of masks, and protection of healthcare workers from COVID-19","volume":"9","author":"R Sommerstein","year":"2020","journal-title":"Antimicrob Resist Infect Control"},{"issue":"4","key":"pone.0287432.ref010","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.jhin.2019.11.010","article-title":"Assessment of the potential for pathogen dispersal during high-flow nasal therapy","volume":"104","author":"M Kotoda","year":"2020","journal-title":"J Hosp Infect"},{"issue":"1","key":"pone.0287432.ref011","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13054-020-03415-2","article-title":"Knowledge translation tools to guide care of non-intubated patients with acute respiratory illness during the COVID-19 Pandemic","volume":"25","author":"D Leasa","year":"2021","journal-title":"Crit Care"},{"issue":"4","key":"pone.0287432.ref012","doi-asserted-by":"crossref","first-page":"e35797","DOI":"10.1371\/journal.pone.0035797","article-title":"Aerosol generating procedures and risk of transmission of acute respiratory infections to healthcare workers: a systematic review","volume":"7","author":"K Tran","year":"2012","journal-title":"PLoS One"},{"issue":"5","key":"pone.0287432.ref013","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1007\/s00134-020-06022-5","article-title":"Surviving Sepsis Campaign: guidelines on the management of critically ill adults with Coronavirus Disease 2019 (COVID-19)","volume":"46","author":"W Alhazzani","year":"2020","journal-title":"Intensive Care Med"},{"issue":"1","key":"pone.0287432.ref014","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s40560-021-00538-8","article-title":"Predictors of failure with high-flow nasal oxygen therapy in COVID-19 patients with acute respiratory failure: a multicenter observational study","volume":"9","author":"R Mellado-Artigas","year":"2021","journal-title":"J Intensive Care"},{"issue":"7","key":"pone.0287432.ref015","doi-asserted-by":"crossref","first-page":"e638","DOI":"10.1097\/CCM.0000000000005474","article-title":"Validation of Respiratory Rate-Oxygenation Index in Patients With COVID-19-Related Respiratory Failure","volume":"50","author":"LC Myers","year":"2022","journal-title":"Crit Care Med"},{"issue":"1","key":"pone.0287432.ref016","first-page":"693","article-title":"High-flow nasal cannula for Acute Respiratory Distress Syndrome (ARDS) due to COVID-19","volume":"15","author":"C Panadero","year":"2020","journal-title":"Multidiscip Respir Med"},{"issue":"1","key":"pone.0287432.ref017","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.pulmoe.2021.04.003","article-title":"COVID-19 Pneumonia and ROX index: Time to set a new threshold for patients admitted outside the ICU","volume":"28","author":"ML Vega","year":"2022","journal-title":"Pulmonology"},{"key":"pone.0287432.ref018","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jcrc.2016.05.022","article-title":"Predicting success of high-flow nasal cannula in pneumonia patients with hypoxemic respiratory failure: The utility of the ROX index","volume":"35","author":"O Roca","year":"2016","journal-title":"J Crit Care"},{"issue":"11","key":"pone.0287432.ref019","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.1164\/rccm.201803-0589OC","article-title":"An Index Combining Respiratory Rate and Oxygenation to Predict Outcome of Nasal High-Flow Therapy","volume":"199","author":"O Roca","year":"2019","journal-title":"Am J Respir Crit Care Med"},{"issue":"1","key":"pone.0287432.ref020","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1186\/s12890-020-01354-w","article-title":"Application of high-flow nasal cannula in hypoxemic patients with COVID-19: a retrospective cohort study","volume":"20","author":"M Hu","year":"2020","journal-title":"BMC Pulm Med"},{"key":"pone.0287432.ref021","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/j.jbi.2014.02.013","article-title":"Sample size estimation in diagnostic test studies of biomedical informatics","volume":"48","author":"K. Hajian-Tilaki","year":"2014","journal-title":"J Biomed Inform"},{"issue":"12","key":"pone.0287432.ref022","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1007\/s00134-020-06228-7","article-title":"Use of nasal high flow oxygen during acute respiratory failure","volume":"46","author":"J-D Ricard","year":"2020","journal-title":"Intensive Care Medicine"},{"issue":"23","key":"pone.0287432.ref023","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1056\/NEJMoa1503326","article-title":"High-Flow Oxygen through Nasal Cannula in Acute Hypoxemic Respiratory Failure","volume":"372","author":"J-P Frat","year":"2015","journal-title":"New England Journal of Medicine"},{"issue":"10","key":"pone.0287432.ref024","doi-asserted-by":"crossref","first-page":"1924","DOI":"10.1007\/s00134-020-06177-1","article-title":"Prediction of outcome of nasal high flow use during COVID-19-related acute hypoxemic respiratory failure","volume":"46","author":"N Zucman","year":"2020","journal-title":"Intensive Care Med"},{"issue":"5","key":"pone.0287432.ref025","doi-asserted-by":"crossref","first-page":"e0268431","DOI":"10.1371\/journal.pone.0268431","article-title":"ROX index and SpO2\/FiO2 ratio for predicting high-flow nasal cannula failure in hypoxemic COVID-19 patients: A multicenter retrospective study","volume":"17","author":"JH Kim","year":"2022","journal-title":"PLoS One"},{"key":"pone.0287432.ref026","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jcrc.2021.08.012","article-title":"ROX index as a good predictor of high flow nasal cannula failure in COVID-19 patients with acute hypoxemic respiratory failure: A systematic review and meta-analysis","volume":"66","author":"J Prakash","year":"2021","journal-title":"J Crit Care"},{"issue":"1","key":"pone.0287432.ref027","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1186\/s12931-020-01462-5","article-title":"The pathophysiology of \u2018happy\u2019 hypoxemia in COVID-19","volume":"21","author":"S Dhont","year":"2020","journal-title":"Respiratory Research"},{"issue":"11","key":"pone.0287432.ref028","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.1007\/s00134-020-06199-9","article-title":"Monitoring of high-flow nasal cannula for SARS-CoV-2 severe pneumonia: less is more, better look at respiratory rate","volume":"46","author":"D Blez","year":"2020","journal-title":"Intensive Care Med"},{"issue":"12","key":"pone.0287432.ref029","first-page":"1","article-title":"Estimating the Area under a Receiver Operating Characteristic Curve For Repeated Measures Design","volume":"8","author":"H Liu","year":"2003","journal-title":"Journal of Statistical Software"},{"issue":"6","key":"pone.0287432.ref030","doi-asserted-by":"crossref","first-page":"909","DOI":"10.4187\/respcare.08631","article-title":"High-Flow Nasal Cannula Therapy in COVID-19: Using the ROX Index to Predict Success","volume":"66","author":"A Chandel","year":"2021","journal-title":"Respir Care"}],"container-title":["PLOS ONE"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0287432","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,21]],"date-time":"2023-06-21T19:11:50Z","timestamp":1687374710000},"score":1,"resource":{"primary":{"URL":"https:\/\/dx.plos.org\/10.1371\/journal.pone.0287432"}},"subtitle":[],"editor":[{"given":"Vijay","family":"Hadda","sequence":"first","affiliation":[],"role":[{"role":"editor","vocabulary":"crossref"}]}],"short-title":[],"issued":{"date-parts":[[2023,6,21]]},"references-count":30,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2023,6,21]]}},"URL":"https:\/\/doi.org\/10.1371\/journal.pone.0287432","relation":{},"ISSN":["1932-6203"],"issn-type":[{"value":"1932-6203","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,6,21]]}}}